DUBLIN–(BUSINESS WIRE)–The “Contact Lenses – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Contact Lenses Market to Reach US$15.8 Billion by the Year 2026 Growth in the global market is b…
Author: Business Wire
Glaukos Corporation Announces Second Quarter 2022 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financ…
Glaukos Announces FDA 510(k) Clearance of iStent infinite®
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Iveric Bio to Present at the Wedbush PacGrow Healthcare Conference 2022
PARSIPPANY, N.J.–(BUSINESS WIRE)–Iveric Bio announced the Company will participate in a fireside chat at the Wedbush PacGrow Healthcare Conference 2022 on Tuesday, August 9, 2022.
OliX Pharmaceuticals Receives IND Approval from FDA to Develop RNAi Therapeutic OLX10212 for Age-related Macular Degeneration
SUWON, South Korea–(BUSINESS WIRE)– #AgeRelatedMacularDegeneration–FDA has approved the OliX Pharmaceuticals’ Investigational New Drug application to develop OLX10212 for age-related macular degeneration.
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PARSIPPANY, N.J.–(BUSINESS WIRE)–Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to two newly-hired, non-executive employees.
Aura Biosciences to Participate at the 2022 BTIG Biotechnology Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that Elisabet de l…
OcuTerra Therapeutics Announces First Patient Dosed in OTT166 Phase 2 DR:EAM Clinical Trial for Diabetic Retinopathy
BOSTON–(BUSINESS WIRE)–OcuTerra announces the first patient was dosed in its Phase 2 DR:EAM clinical trial evaluating OTT166
Aerie Pharmaceuticals Announces First Participant Dosed in the COMET-3 Study of AR-15512 for the Treatment of Dry Eye Disease
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development, and commercialization of first-in-class ophthalmic therapies, today announced that the first participant has been…
LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s sec…
Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify® in the U.S.
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)—- $RDY #Alcon–Dr. Reddy’s Laboratories Ltd. today announced that it has entered into a licensing agreement with Princeton, New Jersey based Slayback Pharma LLC.
Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individu…
EyeCare Partners Expands Presence in Virginia with Addition of Retina Institute of Virginia
ST. LOUIS–(BUSINESS WIRE)–EyeCare Partners Expands Presence in Virginia with Addition of Retina Institute of Virginia
EyeCare Partners Expands Presence in Virginia with Addition of Commonwealth Eye Care Associates
ST. LOUIS–(BUSINESS WIRE)–EyeCare Partners Expands Presence in Virginia with Addition of Commonwealth Eye Care Associates
NovaBay Pharmaceuticals Targets New Market with Antimicrobial Avenova® Lid and Lash Spray for Lash Extensions
EMERYVILLE, Calif.–(BUSINESS WIRE)—- $NBY #Avenova–NovaBay Pharmaceuticals targets the lash extension market with antimicrobial Avenova lid and lash spray.
Palm Medical Centers Announces Agreement to Acquire Trinity Family Health Care Center in Port Richey
CORAL GABLES, Fla.–(BUSINESS WIRE)–In its ongoing commitment to provide the best, most comprehensive and affordable health care service to seniors in Florida, Palm Medical Centers, an MBF Healthcare Partners II, L.P. (“MBF”) portfolio company, announ…
Harrow Health to Announce Second Quarter 2022 Financial Results on August 9, 2022
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow Health, Inc. (Nasdaq: HROW), an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible a…
Walmart Partners with WALDO to Offer Affordable Contact Lenses
BENTONVILLE, Ark.–(BUSINESS WIRE)–Walmart and WALDO are partnering to make eyecare more accessible and affordable. Walmart is the first exclusive retailer to offer WALDO, an innovative and accessible eyecare brand that believes in the power of positi…
Versant Health Names Hayley Ellington-Buckles Chief Compliance and Privacy Officer
BALTIMORE–(BUSINESS WIRE)– #compliance–Chief Compliance and Privacy Officer Hayley Ellington-Buckles brings significant managed healthcare experience and deep institutional knowledge
Iveric Bio Reports Second Quarter 2022 Operational Highlights and Financial Results
PARSIPPANY, N.J.–(BUSINESS WIRE)–Iveric Bio announced financial and operating results for the second quarter ended June 30, 2022 and provided a general business update.